EMERGE HEALTH INTERNATIONAL INC: 10-Q filed 2015-02-17
What EMERGE HEALTH INTERNATIONAL INC reported in its quarterly report filed 2015-02-17 (fiscal Q2 2015): 21 published measures, 50 facts as tagged in accession 0001264931-15-000085.
This filing
- Form
- 10-Q (quarterly report)
- Filed
- 2015-02-17
- Fiscal period
- fiscal Q2 2015
- Accession
- 0001264931-15-000085 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; a measure with a published history links to it, and the history shows the latest-filed value per period. All EMERGE HEALTH INTERNATIONAL INC filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-12-31 | 1,576,318 | USD | |
| At 2014-06-30 | 1,671,282 | USD |
Total liabilities
Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-12-31 | 267,260 | USD | |
| At 2014-06-30 | 332,243 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-12-31 | 1,309,058 | USD | |
| At 2014-06-30 | 1,339,039 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-12-31 | 63,714 | USD | |
| At 2014-06-30 | 36,836 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-09-30 to 2014-12-31 | 40,228 | USD | 93 |
| 2014-07-01 to 2014-12-31 | -29,982 | USD | 184 |
| 2013-09-30 to 2013-12-31 | -29,264 | USD | 93 |
| 2013-07-01 to 2013-12-31 | 52,422 | USD | 184 |
Financing cash flow
Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-07-01 to 2014-12-31 | -16,914 | USD | 184 |
| 2013-07-01 to 2013-12-31 | -2,674 | USD | 184 |
Investing cash flow
Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-07-01 to 2014-12-31 | -15,307 | USD | 184 |
| 2013-07-01 to 2013-12-31 | -20,176 | USD | 184 |
Net property, plant and equipment
Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-12-31 | 359,623 | USD | |
| At 2014-06-30 | 379,064 | USD |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-09-30 to 2014-12-31 | 50,750 | USD | 93 |
| 2014-07-01 to 2014-12-31 | -20,367 | USD | 184 |
| 2013-09-30 to 2013-12-31 | -11,780 | USD | 93 |
| 2013-07-01 to 2013-12-31 | 69,691 | USD | 184 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-12-31 | 968,548 | USD | |
| At 2014-06-30 | 1,046,055 | USD |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-12-31 | 189,359 | USD | |
| At 2014-06-30 | 237,428 | USD |
Current accounts payable
Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-12-31 | 101,900 | USD | |
| At 2014-06-30 | 224,262 | USD |
Net inventory
Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-12-31 | 725,417 | USD | |
| At 2014-06-30 | 815,192 | USD |
Gross profit
Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-09-30 to 2014-12-31 | 228,490 | USD | 93 |
| 2014-07-01 to 2014-12-31 | 353,606 | USD | 184 |
| 2013-09-30 to 2013-12-31 | 190,439 | USD | 93 |
| 2013-07-01 to 2013-12-31 | 450,450,488 | USD | 184 |
Common shares outstanding
Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-12-31 | 15,221,647 | shares | |
| At 2014-06-30 | 15,221,647 | shares |
Additional paid-in capital
Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-12-31 | 1,899,781 | USD | |
| At 2014-06-30 | 1,899,773 | USD |
Accumulated depreciation on property, plant and equipment
Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-12-31 | -1,106,551 | USD | |
| At 2014-06-30 | -1,071,802 | USD |
Depreciation expense
Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-09-30 to 2014-12-31 | 6,894 | USD | 93 |
| 2014-07-01 to 2014-12-31 | 13,788 | USD | 184 |
| 2013-09-30 to 2013-12-31 | 4,715 | USD | 93 |
| 2013-07-01 to 2013-12-31 | 9,827 | USD | 184 |
Deferred income tax expense or benefit
The deferred portion of income tax expense or benefit, arising from timing differences. It is not tax paid in the period.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-07-01 to 2014-12-31 | -1,984 | USD | 184 |
| 2013-07-01 to 2013-12-31 | 10,906 | USD | 184 |
Change in accounts receivable
The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-07-01 to 2014-12-31 | 6,703 | USD | 184 |
| 2013-07-01 to 2013-12-31 | 47,259 | USD | 184 |
Change in inventories
The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-07-01 to 2014-12-31 | 89,775 | USD | 184 |
| 2013-07-01 to 2013-12-31 | -69,026 | USD | 184 |
Inspect the source
- Entity
- EMERGE HEALTH INTERNATIONAL INC / CIK 0000032567
- Captured
- SEC response SHA-256
ccc4af770e79b095a8863560b1e3ccab7d296bc5e1172eb71ea3e8a8cfe03817
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0000032567.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))